Immuneering Q3 EPS $(0.38) Beats $(0.39) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsNews
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.39) by 3.06 percent. This is a 22.45 percent increase over losses of $(0.49) per share from the
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.39) by 3.06 percent. This is a 22.45 percent increase over losses of $(0.49) per share from the same period last year.